Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma
Antibodies targeting a tumor antigen, GD2, show some efficacy for neuroblastoma but induce severe neuropathic pain and peripheral neuropathy. Here the authors design a gated chimeric antigen receptor (CAR), using GD2 as the gate and another tumor antigen, B7H3, as the target, to find this GD2-B7H3 C...
Saved in:
| Main Authors: | Babak Moghimi, Sakunthala Muthugounder, Samy Jambon, Rachelle Tibbetts, Long Hung, Hamid Bassiri, Michael D. Hogarty, David M. Barrett, Hiroyuki Shimada, Shahab Asgharzadeh |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/92c07d10ceed4a499ccaa1bcf1c46793 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma
by: Nicola Tumino, et al.
Published: (2021) -
A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma
by: Tim van Groningen, et al.
Published: (2019) -
Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma
by: Stefan Nierkens, et al.
Published: (2021) -
A Novel pH-Sensitive Multifunctional DNA Nanomedicine: An Enhanced and Harmless GD2 Aptamer-Mediated Strategy for Guiding Neuroblastoma Antitumor Therapy
by: Zhang L, et al.
Published: (2021) -
Quality assessment of Urochloa (syn. Brachiaria) seeds produced in Cameroon
by: Njehoya Clémence-Aggy, et al.
Published: (2021)